Standard preimplantation genetic testing (PGT) helps identify embryos with the correct number of chromosomes, detecting abnormalities (aneuploidies) and partial changes (mosaicism) that could affect pregnancy success. But even with correct chromosome numbers, it misses the thousands of genetic diseases hidden within an embryo's DNA sequence.

A single genetic mutation can mean the difference between a healthy baby and a severe, lifelong disease. Today, 1 in 10 families face this tragic reality, struck by a genetic disease that slips through the cracks of current preimplantation testing.

Our calling is to use genetics to transform uncertainty into trust, and statistics into clarity. From the start, we safeguard the futures of families and those undergoing IVF. This is the new standard of care that every IVF journey deserves. This is GenEmbryomics, supporting health and success, hand in hand.